XML 39 R24.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 1 - Organization and Nature of Business (Details Textual)
2 Months Ended 12 Months Ended
Jul. 27, 2016
$ / shares
shares
Jun. 17, 2016
shares
Apr. 15, 2016
USD ($)
$ / shares
shares
Mar. 02, 2016
USD ($)
shares
Feb. 13, 2016
Feb. 12, 2016
USD ($)
$ / shares
shares
Apr. 15, 2016
USD ($)
$ / shares
shares
Dec. 31, 2016
USD ($)
$ / shares
shares
Dec. 31, 2015
USD ($)
$ / shares
shares
Jul. 28, 2016
shares
Jul. 26, 2016
$ / shares
shares
Preferred Stock, Par or Stated Value Per Share | $ / shares               $ 0.000001 $ 0.000001    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross               1,308,300      
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares               $ 1.25      
Stock Issued During Period, Shares, Reverse Stock Split, Post-split 25,867                    
Common Stock, Par or Stated Value Per Share | $ / shares $ 0.0001         $ 0.0001   $ 0.0001 $ 0.0001   $ 0.000001
Number of Wholly-Owned Subsidiaries Split Off         29            
Stock Issued During Period, Value, New Issues | $               $ 4,761,797      
Stock Issued During Period, Value, Conversion of Convertible Securities | $               $ 75,265      
Common Stock, Shares Authorized 400,000,000             100,000,000 100,000,000   100,000,000,000
Preferred Stock, Shares Outstanding               0 0 872,766  
Conversion of Stock, Shares Issued 10,146,000                    
Stock Conversion from Series B Preferred Stock to Common Stock [Member]                      
Convertible Preferred Stock, Shares Issued upon Conversion   1                  
Conversion of Stock, Shares Converted 10,146,000                    
Preferred Stock, Shares Outstanding 11,018,766                    
Conversion of Stock, Shares Issued 10,146,000                    
Private Placement [Member] | Commissions [Member]                      
Payments of Stock Issuance Costs | $     $ 373,778                
Momspot LLC [Member]                      
Noncontrolling Interest, Ownership Percentage by Parent           51.00%          
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners           49.00%          
Interest Ownership Split Off         51.00%            
Investors in the Private Offering [Member]                      
Number of Common Stock Held As Converted Basis           2,775,000          
Debt Principal Conversion to Predecessor Warrants [Member]                      
Debt Conversion, Original Debt, Amount | $           $ 665,000          
Debt Interest Conversion to Predecessor Warrants [Member]                      
Debt Conversion, Original Debt, Amount | $           35,000          
Conversion of Outstanding Stockholder Debt [Member] | Chairman and Board Member Garo H. Armen [Member]                      
Stock Issued During Period, Value, Conversion of Convertible Securities | $           350,000          
Conversion of Outstanding Stockholder Debt [Member] | Predecessor's Stockholder [Member]                      
Stock Issued During Period, Value, Conversion of Convertible Securities | $           $ 150,000          
Common Stock [Member]                      
Stock Issued During Period, Shares, Reverse Stock Split, Post-split           25,867          
Stock Issued During Period, Value, New Issues | $                    
Stock Issued During Period, Value, Conversion of Convertible Securities | $               6      
Placement Agent Warrants [Member] | Private Placement [Member]                      
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares     $ 1.25       $ 1.25        
Series B Preferred Stock [Member]                      
Proceeds from Issuance of Convertible Preferred Stock | $               $ 4,283,437    
Series B Preferred Stock [Member] | Reverse Stock Split [Member]                      
Stockholders' Equity Note, Stock Split, Conversion Ratio   15,463.7183                  
Series B Preferred Stock [Member] | Private Placement [Member]                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           423,291          
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares           $ 1.25          
Shares Issued, Price Per Share | $ / shares           $ 1.25          
Stock Issued During Period, Value, New Issues | $           $ 3,468,750          
Stock Issued During Period, Shares, New Issues     420,260 913,200     4,108,460        
Proceeds from Issuance of Convertible Preferred Stock | $     $ 525,325 $ 1,141,500              
Proceeds from Issuance of Private Placement | $             $ 4,635,575        
Proceeds From Issuance of Private Placement, Net of Issuance Costs | $             4,261,797        
Series B Preferred Stock [Member] | Private Placement [Member] | Including Conversion of Principal and Interest [Member]                      
Proceeds from Issuance of Private Placement | $             5,135,575        
Proceeds From Issuance of Private Placement, Net of Issuance Costs | $             $ 4,761,797        
Series B Preferred Stock [Member] | Placement Agent Warrants [Member] | Private Placement [Member]                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights     127,346       127,346        
Class of Warrant or Right, Value of Securities Called by Warrants or Rights | $     $ 146,641       $ 146,641        
Series B Preferred Stock [Member] | Predecessor Warrants [Member]                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           295,945          
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares           $ 1.25          
Warrants Issued for Settlement and Conversion of Debt | $           $ 340,784          
Series B Convertible Preferred Stock [Member]                      
Preferred Stock, Par or Stated Value Per Share | $ / shares               $ 0.000001 $ 0.000001    
Conversion of Stock, Shares Converted               10,146,000      
Preferred Stock, Shares Outstanding               872,766 0    
Protagenic Therapeutics Inc [Member]                      
Business Acquisition, Conversion of Stock, Ratio           1          
Business Combination, Stock Warrant Conversion Ratio           1          
Stock Issued During Period, Shares, Conversion of Series A Preferred Stock to Series B Preferred Stock           297,468          
Protagenic Therapeutics Inc [Member] | Private Placement [Member]                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           3,403,367          
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares           $ 1.05          
Protagenic Therapeutics Inc [Member] | Placement Agent Warrants [Member]                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           127,346          
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares           $ 1.25          
Protagenic Therapeutics Inc [Member] | Predecessor Warrants [Member]                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           295,945          
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares           $ 1.25          
Protagenic Therapeutics Inc [Member] | Series B Preferred Stock [Member]                      
Common Shares Exchanged for Preferred Shares           (6,612,838)          
Preferred Stock, Par or Stated Value Per Share | $ / shares           $ 0.000001          
Protagenic Therapeutics Inc [Member] | Series B Preferred Stock [Member] | New Warrants [Member]                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           3,403,367          
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares           $ 1.03          
Protagenic Therapeutics Inc [Member] | Series B Preferred Stock [Member] | New Options [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross           1,807,744          
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares           $ 0.87          
Protagenic Therapeutics Inc [Member] | Series B Preferred Stock [Member] | Predecessor Options [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross           17,784          
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares           $ 1.25          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           295,945